NASDAQ:IPOA Teladoc Health (IPOA) Stock Price, News & Analysis → Most important medical advance in 100 years (From The Oxford Club) (Ad) Free IPOA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.66▼$11.8150-Day Range$11.79▼$11.7952-Week Range N/AVolume6.45 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Teladoc Health alerts: Email Address Ad The Oxford ClubMost important medical advance in 100 yearsThis is going to dramatically alter medicine forever. Keep in mind, creating a new effective drug in the past took up to 10 years and could cost up to $12 billion. But now, with artificial intelligence, it could take months and cost a fraction of that amount.Watch my new presentation detailing the opportunity About Teladoc Health Stock (NASDAQ:IPOA)Social Capital Hedosophia Holdings Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2017 and is based in Palo Alto, California.Read More Ad The Oxford ClubMost important medical advance in 100 yearsThis is going to dramatically alter medicine forever. Keep in mind, creating a new effective drug in the past took up to 10 years and could cost up to $12 billion. But now, with artificial intelligence, it could take months and cost a fraction of that amount.Watch my new presentation detailing the opportunity IPOA Stock News HeadlinesMay 10, 2024 | forbes.comIHeart, Teladoc, WeWork, Zoom: Former Hot Stocks Hit The SkidsApril 30, 2024 | msn.comAvoid Teladoc, Roku, and MobileyeMay 11, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 30, 2024 | fool.comTeladoc Health Reports Mixed ResultsApril 26, 2024 | markets.businessinsider.com13 Analysts Assess Teladoc Health: What You Need To KnowApril 26, 2024 | markets.businessinsider.comTeladoc’s Hold Rating: Balancing Integrated Care Success Against BetterHelp Uncertainties and Strategic TransitionApril 26, 2024 | msn.comTeladoc Health (TDOC) Q1 2024 Earnings Call TranscriptApril 25, 2024 | markets.businessinsider.comTDOC Stock Earnings: Teladoc Health Misses EPS, Beats Revenue for Q1 2024May 11, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 25, 2024 | marketwatch.comTeladoc Health Posts Wider 1Q LossApril 25, 2024 | gurufocus.comTeladoc Health Inc. (TDOC) Q1 2024 Earnings: Misses on EPS, Surpasses Revenue ExpectationsApril 24, 2024 | msn.comTeladoc Health Q1 Preview: Mental health segment could help earningsApril 17, 2024 | markets.businessinsider.comTDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost MoneyApril 6, 2024 | msn.comTeladoc Stock (NYSE:TDOC): No Need to Risk Your Financial HealthApril 5, 2024 | msn.comTeladoc Health (NYSE:TDOC) CEO Abruptly Departs; CFO Takes Helm Amid TransitionApril 5, 2024 | msn.comTeladoc's CEO departs suddenly as visits are down and the stock sinksApril 5, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alnylam Pharma (ALNY)April 5, 2024 | markets.businessinsider.comWhat 9 Analyst Ratings Have To Say About Teladoc HealthApril 5, 2024 | marketwatch.comTeladoc Health Names Mala Murthy Acting CEO as Jason Gorevic DepartsMarch 18, 2024 | benzinga.comHow Is The Market Feeling About Teladoc Health?February 26, 2024 | forbes.comLeading A Healthcare Revolution: Teladoc CEO’s Telemedicine JourneyFebruary 26, 2024 | markets.businessinsider.comWhere Teladoc Health Stands With AnalystsFebruary 21, 2024 | msn.comTeladoc stock is plunging because virtual doctor's visits aren't what they used to beFebruary 21, 2024 | msn.comTeladoc sends health tech stocks lower after Q4 resultsFebruary 21, 2024 | msn.comTeladoc Health Stock Is Plunging. What the CEO Said After Earnings Missed.February 21, 2024 | benzinga.comTeladoc Health Delivers Mixed Results, 'Sobering' Guidance: 6 Analysts Provide Key TakeawaysFebruary 21, 2024 | msn.comWhy Is Teladoc Health (TDOC) Stock Down 21% Today?See More Headlines Receive IPOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Conglomerates Sub-IndustryN/A Current SymbolNASDAQ:IPOA CUSIPN/A CIKN/A Webwww.socialcapitalhedosophiaholdings.com Phone650-521-9007FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Chamath Palihapitiya (Age 42)CEO & Chairman Mr. Ian Osborne (Age 36)Pres & Director Mr. Steven Trieu (Age 40)Chief Financial Officer Mr. Simon Williams (Age 39)Gen. Counsel & Sec. Key CompetitorsCresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y AgropecuariaNASDAQ:CRESWFalcon's Beyond GlobalNASDAQ:FBYDWADS-TEC EnergyNASDAQ:ADSEWAeries TechnologyNASDAQ:AERTWAir TNASDAQ:AIRTPView All Competitors IPOA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Teladoc Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Okta (OKTA), PayPal (PYPL), Adobe (ADBE), Salesforce (CRM), Pfizer (PFE), Shopify (SHOP), Trade Desk (TTD), Twilio (TWLO) and Visa (V). This page (NASDAQ:IPOA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithMost important medical advance in 100 yearsThe Oxford ClubA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teladoc Health Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
